ArticleGynecologic oncology2026
AXL inhibition improves the therapeutic efficacy of trastuzumab in high-risk endometrial cancer.
Jo'an Tankou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleGynecologic oncology2026
Jo'an Tankou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.